Pharmacogenetics of Antiretroviral Drugs

NCT00435656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2011-08-25

No results posted yet for this study

Summary

In this research project, we will study the genetic determinants that influence the pharmacokinetics of antiretroviral drugs used in the treatment of diseases caused by the HIV.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Université Catholique de Louvain

    collaborator OTHER
  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Vincent Haufroid, PharmD PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00435656 on ClinicalTrials.gov